{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:07:24Z","timestamp":1787508444634,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003624","name":"Ministry of Agriculture, Food and Rural Affairs","doi-asserted-by":"publisher","award":["320104-03"],"award-info":[{"award-number":["320104-03"]}],"id":[{"id":"10.13039\/501100003624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003668","name":"Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF- 2020R1I1A1A01070867"],"award-info":[{"award-number":["NRF- 2020R1I1A1A01070867"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.heliyon.2023.e19341","type":"journal-article","created":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T01:04:46Z","timestamp":1692493486000},"page":"e19341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K"],"prefix":"10.1016","volume":"9","author":[{"given":"Vinothini","family":"Boopathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnatun","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanapriya","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathiyamoorthy","family":"Subramaniyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Man","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Uk","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Mathiyalagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se","family":"Chan Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2023.e19341_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/JCMA.0000000000000270","article-title":"The outbreak of COVID-19: an overview","volume":"83","author":"Wu","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"issue":"9371","key":"10.1016\/j.heliyon.2023.e19341_bib2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e19341_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMe2001126","article-title":"Another decade, another coronavirus","volume":"382","author":"Perlman","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Ann. Rev. Virol."},{"key":"10.1016\/j.heliyon.2023.e19341_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10311-020-01091-w","article-title":"Air pollution by NO 2 and PM 2.5 explains COVID-19 infection severity by overexpression of angiotensin-converting enzyme 2 in respiratory cells: a review","volume":"19","author":"Paital","year":"2021","journal-title":"Environ. Chem. Lett."},{"key":"10.1016\/j.heliyon.2023.e19341_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61390","article-title":"ACE2: evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities","volume":"9","author":"Zamorano Cuervo","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2023.e19341_bib8","article-title":"Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment","volume":"22","author":"Pang","year":"2021","journal-title":"Obes. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19341_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e19341_bib10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19341_bib12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1165\/rcmb.2020-0322PS","article-title":"Targeting ACE2 for COVID-19 therapy: opportunities and challenges","volume":"64","author":"Jia","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19341_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e19341_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009820","article-title":"TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction","volume":"17","author":"Khan","year":"2021","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19341_bib15","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2353\/ajpath.2010.090665","article-title":"TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells","volume":"176","author":"Chen","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"21","key":"10.1016\/j.heliyon.2023.e19341_bib16","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2023.e19341_bib18","unstructured":"Estimates Of Excess Mortality Attributable To Covid-19. Population and Development Review. n\/a(n\/a)."},{"key":"10.1016\/j.heliyon.2023.e19341_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.628144","article-title":"Drug repurposing strategy (DRS): emerging approach to identify potential therapeutics for treatment of novel coronavirus infection","volume":"8","author":"Sahoo","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19341_bib20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s43440-020-00155-6","article-title":"Drug repurposing approach to fight COVID-19","volume":"72","author":"Singh","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19341_bib21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s43440-020-00155-6","article-title":"Drug repurposing approach to fight COVID-19","volume":"72","author":"Singh","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.heliyon.2023.e19341_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.877813","article-title":"Repurposing of FDA approved drugs against SARS-CoV-2 papain-like protease: computational, biochemical, and in vitro studies","volume":"13","author":"Kulandaisamy","year":"2022","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19341_bib23","first-page":"651","article-title":"Drug discovery and development: role of basic biological research","volume":"3","author":"Mohs","year":"2017","journal-title":"Alzh. Dem."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19341_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19341_bib26","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/bib\/bbz103","article-title":"Computational\/in silico methods in drug target and lead prediction","volume":"21","author":"Agamah","year":"2020","journal-title":"Briefings Bioinf."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19341_bib27","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e19341_bib28","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-based virtual screening for drug discovery: principles, applications and recent advances","volume":"14","author":"Lionta","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19341_bib29","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/jm2010332","article-title":"Rational approaches to improving selectivity in drug design","volume":"55","author":"Huggins","year":"2012","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19341_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/2231-4040.104709","article-title":"Natural products derived from plants as a source of drugs","volume":"3","author":"Veeresham","year":"2012","journal-title":"\\\"J. Adv. Pharm. Technol. Research\\\"\\\" (JAPTR)\\\""},{"key":"10.1016\/j.heliyon.2023.e19341_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.584158","article-title":"Potential simultaneous inhibitors of angiotensin-converting enzyme 2 and transmembrane protease, serine 2","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e19341_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110816","article-title":"GB-2 inhibits ACE2 and TMPRSS2 expression: in vivo and in vitro studies","volume":"132","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e19341_bib33","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/acs.jafc.3c00285","article-title":"Bioactive compositions of cinnamon (cinnamomum verum J. Presl) extracts and their capacities in suppressing SARS-CoV-2 spike protein binding to ACE2, inhibiting ACE2, and scavenging free radicals","volume":"71","author":"Xie","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"Suppl","key":"10.1016\/j.heliyon.2023.e19341_bib34","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2001.16.S.S3","article-title":"Brief introduction of Panax ginseng C.A. Meyer","volume":"16","author":"Yun","year":"2001","journal-title":"J. Kor. Med. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jgr.2019.06.004","article-title":"A survey of biomolecular sequences in genus Panax","volume":"44","author":"Boopathi","year":"2020","journal-title":"J. Gins. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19341_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jgr.2017.10.004","article-title":"Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases","volume":"42","author":"Kim","year":"2018","journal-title":"J. Gin. Res."},{"key":"10.1016\/j.heliyon.2023.e19341_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110915","article-title":"Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: pharmacology and mechanisms","volume":"132","author":"Fan","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19341_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jgr.2017.01.008","article-title":"Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions","volume":"42","author":"Mohanan","year":"2018","journal-title":"J. Gins. Res."},{"key":"10.1016\/j.heliyon.2023.e19341_bib39","series-title":"Future Medicine","first-page":"1091","article-title":"Ginseng nanoparticles: a budding tool for cancer treatment","author":"Mathiyalagan","year":"2017"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19341_bib40","article-title":"In vitro evaluation of anti-lung cancer and anti-COVID-19 effects using fermented black color ginseng extract","volume":"16","author":"Han","year":"2021","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.heliyon.2023.e19341_bib41","series-title":"Corona-Cov-2 (COVID-19) and Ginseng: Comparison of Possible Use in COVID-19 and Influenza","first-page":"535","author":"Lee","year":"2021"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19341_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jgr.2022.01.002","article-title":"COVID-19 and Panax ginseng: targeting platelet aggregation, thrombosis and the coagulation pathway","volume":"46","author":"Lee","year":"2022","journal-title":"J. Gin. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19341_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jgr.2022.01.003","article-title":"Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: a systematic review","volume":"46","author":"Hossain","year":"2022","journal-title":"J. Gins. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19341_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jgr.2022.02.003","article-title":"Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic","volume":"46","author":"Jung","year":"2022","journal-title":"J. Gins. Res."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e19341_bib45","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/molecules26134095","article-title":"Pharmacological efficacy of ginseng against respiratory tract infections","volume":"26","author":"Alsayari","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8546-5-20","article-title":"Pharmacology of ginsenosides: a literature review","volume":"5","author":"Leung","year":"2010","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/ijms20010094","article-title":"Potential dissociative glucocorticoid receptor activity for protopanaxadiol and protopanaxatriol","volume":"20","author":"Karra","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19341_bib48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1476-5381.2008.00066.x","article-title":"Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells","volume":"156","author":"Leung","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e19341_bib49","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s40121-021-00500-z","article-title":"Potential adverse effects of dexamethasone therapy on COVID-19 patients: review and recommendations","volume":"10","author":"Chen","year":"2021","journal-title":"Inf. Dis. Ther."},{"key":"10.1016\/j.heliyon.2023.e19341_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2020.12.001","article-title":"Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2","volume":"554","author":"Zhang","year":"2021","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19341_bib51","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1042\/EBC20210005","article-title":"Roles of steroid receptors in the lung and COVID-19","volume":"65","author":"Leach","year":"2021","journal-title":"Essays Biochem."},{"issue":"7813","key":"10.1016\/j.heliyon.2023.e19341_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/d41586-020-01824-5","article-title":"Coronavirus breakthrough: dexamethasone is first drug shown to save lives","volume":"582","author":"Ledford","year":"2020","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.heliyon.2023.e19341_bib53","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e19341_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.carbpol.2014.05.098","article-title":"Ginsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studies","volume":"112","author":"Mathiyalagan","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.heliyon.2023.e19341_bib55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fitote.2014.11.019","article-title":"A review of biotransformation and pharmacology of ginsenoside compound K","volume":"100","author":"Yang","year":"2015","journal-title":"Fitoterapia"},{"issue":"19","key":"10.1016\/j.heliyon.2023.e19341_bib56","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3390\/nano12193427","article-title":"Production of minor ginsenoside CK from major ginsenosides by biotransformation and its advances in targeted delivery to tumor tissues using nanoformulations","volume":"12","author":"Murugesan","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.heliyon.2023.e19341_bib57","year":"2022","journal-title":"PubChem. PubChem."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e19341_bib58","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"7807","key":"10.1016\/j.heliyon.2023.e19341_bib59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2023.e19341_bib61","series-title":"ProteinsPlus: a Comprehensive Collection of Web-Based Molecular Modeling Tools","author":"Sch\u00f6ning-Stierand","year":"2022"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19341_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib63","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool. CCP4 Newsl","volume":"40","author":"DeLano","year":"2002","journal-title":"Protein Crystallogr,"},{"key":"10.1016\/j.heliyon.2023.e19341_bib64","series-title":"Biovia","author":"Systems","year":"2022"},{"issue":"16","key":"10.1016\/j.heliyon.2023.e19341_bib65","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e19341_bib66","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e19341_bib67","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"W1","key":"10.1016\/j.heliyon.2023.e19341_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2023.e19341_bib69","series-title":"Dendropanax Morbifera Extract-Mediated Zno Nanoparticles Loaded With Indole-3-Carbinol For Enhancement Of Anticancer Efficacy In The A549 Human Lung Carcinoma Cell Line","first-page":"3197","author":"Rupa","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e19341_bib70","series-title":"Terminalia ferdinandiana (Kakadu Plum)-Mediated Bio-Synthesized ZnO Nanoparticles for Enhancement of Anti-Lung Cancer and Anti-Inflammatory Activities","first-page":"3081","author":"Ramadhania","year":"2022"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19341_bib71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/acsptsci.2c00003","article-title":"Allosteric site of ACE-2 as a drug target for COVID-19","volume":"5","author":"Dutta","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19341_bib72","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1021\/acs.jcim.1c00560","article-title":"Key interacting residues between RBD of SARS-CoV-2 and ACE2 receptor: combination of molecular dynamics simulation and density functional calculation","volume":"61","author":"Jawad","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.heliyon.2023.e19341_bib73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fmolb.2021.666626","article-title":"Computational identification of a putative allosteric binding pocket in tmprss2","volume":"8","author":"Sgrignani","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.heliyon.2023.e19341_bib74","first-page":"1","article-title":"Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation","author":"Fraser","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"6965","key":"10.1016\/j.heliyon.2023.e19341_bib75","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19341_bib76","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin\u2010converting enzyme 2 (ACE2), SARS\u2010CoV\u20102 and the pathophysiology of coronavirus disease 2019 (COVID\u201019)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e19341_bib77","article-title":"Camostat mesylate may reduce severity of coronavirus disease 2019 sepsis: a first observation","volume":"2","author":"Hofmann-Winkler","year":"2020","journal-title":"Crit. Care Explor."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19341_bib78","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","article-title":"The impact of natural products upon modern drug discovery","volume":"12","author":"Ganesan","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19341_bib79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1359-6446(02)02556-4","article-title":"Chris Lipinski discusses life and chemistry after the rule of five","volume":"8","author":"Lipinski","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2023.e19341_bib80","volume":"142","author":"Tsai","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e19341_bib81","volume":"132","author":"Wu","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e19341_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120930","article-title":"SARS-CoV-2 infection and replication kinetics in different human cell types: the role of autophagy, cellular metabolism and ACE2 expression","volume":"308","author":"Bartolomeo","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2023.e19341_bib83","series-title":"Angiotensin-Converting Enzyme 2 Is A Functional Receptor For The SARS Coronavirus","first-page":"450","author":"Li","year":"2003"},{"key":"10.1016\/j.heliyon.2023.e19341_bib84","series-title":"Evidence Of The COVID-19 Virus Targeting The CNS: Tissue Distribution, Host\u2013Virus Interaction, And Proposed Neurotropic Mechanisms","first-page":"995","author":"Baig","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e19341_bib85","series-title":"Single-Cell RNA-Seq Data Analysis On The Receptor ACE2 Expression Reveals The Potential Risk Of Different Human Organs Vulnerable To 2019-Ncov Infection","first-page":"185","author":"Zou","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e19341_bib86","series-title":"Systematic Profiling Of ACE2 Expression In Diverse Physiological And Pathological Conditions For COVID\u201019\/SARS\u2010Cov\u20102","first-page":"9478","author":"Li","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e19341_bib87","series-title":"Distribution Of ACE2, CD147, CD26, And Other SARS\u2010Cov\u20102 Associated Molecules In Tissues And Immune Cells In Health And In Asthma, COPD, Obesity, Hypertension, And COVID\u201019 Risk Factors","first-page":"2829","author":"Radzikowska","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e19341_bib88","series-title":"TMPRSS2: Potential Biomarker for COVID\u201019 Outcomes","author":"Strope","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e19341_bib89","series-title":"High Expression Of ACE2 Receptor Of 2019-Ncov On The Epithelial Cells Of Oral Mucosa","first-page":"1","author":"Xu","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e19341_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.647826","article-title":"TMPRSS2 serves as a prognostic biomarker and correlated with immune infiltrates in breast invasive cancer and lung adenocarcinoma","volume":"9","author":"Xiao","year":"2022","journal-title":"Front. Mol. Biosci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023065490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023065490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:06:34Z","timestamp":1784927194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023065490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2405844023065490"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19341","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e19341"}}